Bio-Research

BioResearch Pharma S.A. is a clinical-stage biotechnology company based in Warsaw, Poland, specializing in the development of innovative topical therapies for dermatological conditions. The company utilizes a drug repurposing strategy, identifying new therapeutic applications for established, clinically tested substances to reduce development time, cost, and risk. Its lead program, BRP-011, is a prostaglandin analogue being developed for the treatment of androgenetic alopecia (hair loss) in both men and women. Another key program, BRP-007, targets plaque psoriasis and atopic dermatitis by inhibiting multiple pro-inflammatory cytokines. By leveraging the 505(b)(2) and hybrid regulatory pathways, BioResearch Pharma aims to deliver safer and more effective treatments to market with reduced risk compared to new chemical entities.